Alto Neuroscience, Inc. (ANRO) Stock Statistics & Valuation Metrics

Alto Neuroscience, Inc. has a market cap or net worth of $1.26B. The enterprise value is $909.40.

Alto Neuroscience, Inc. has 39,242,104 shares outstanding. The number of shares has decreased by -2.65% in one year.

Alto Neuroscience, Inc.’s return on equity (ROE) is -0.42 and return on invested capital (ROIC) is -38.15%.

The current PE Ratio of Alto Neuroscience, Inc. is ―. Alto Neuroscience, Inc.’s PEG ratio is 0.66.

In the last 12 months, Alto Neuroscience, Inc. had revenue of 0.00 and earned -63.24M in profits. Earnings per share was -2.19.

In the last 12 months, operating cash flow was -68.28M and capital expenditures -556.00K, giving a free cash flow of -68.84M billion.

Alto Neuroscience, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Alto Neuroscience, Inc. upcoming earnings date is Mar 24, 2027, After Close (Confirmed).

Alto Neuroscience, Inc. as a current ratio of 15.69, with Debt / Equity ratio of 3.22%

In the past 12 months, Alto Neuroscience, Inc. has paid 0.00 in taxes.

Alto Neuroscience, Inc. EV to EBITDA ratio is -5.68, with an EV/FCF ratio of -6.59.

Alto Neuroscience, Inc. has $243.73M in cash and marketable securities with $7.05M in debt, giving a net cash position of $236.68M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Alto Neuroscience, Inc. is $42.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy